Precision Business Insights (PBI) in its report titled “Global Cardiac Guidewire and Catheters Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025” assesses the market performance over seven years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

 

The global cardiac guidewire and catheters market was valued at US$ 1,043.7 Mn in 2018 and increasing at a significant CAGR over the forecast timeframe owing to surge in the prevalence of cardiac disorders around the globe. For instance, according to World Health Organization, approximately 17.9 Mn deaths occurring due to cardiovascular diseases each year around the globe. Moreover, rise in preference for the minimally invasive surgical procedures, government initiations to improve the healthcare infrastructure, favorable reimbursement guidelines, and development of innovative devices are anticipated to propel the cardiac guidewire and catheters market over the forecast years. However, high cost for the devices, risks associated regarding the surgical procedure, and dearth of skilled professionals are anticipated to dampen the global cardiac guidewire and catheters market.

Global cardiac guidewire and catheters market segmented on the basis of product type, end user, and region

 

For more sample: https://www.precisionbusinessinsights.com/request-sample?product_id=15638

 

Coronary Balloons Dominate the Global Cardiac Guidewire and Catheters Market

Based on the product type, global cardiac guidewire and catheters market segmented into coronary balloons, diagnostic catheters, aspiration catheters, and others. Coronary balloons dominated the global cardiac guidewire and catheters market in 2018 and estimated to dominate over the forecast period owing to innovation and launch of technologically advanced coronary balloons by the companies. For instance, in June 2017, OrbusNeich launched Sapphire percutaneous coronary angiography balloon dilatation catheters. However, a stagnant growth rate observed for the diagnostic catheters due to surge in the health awareness among the population and government initiations for the early stage disease diagnosis

 

North America Leads the Global Cardiac Guidewire and Catheters Market

PBI’s global cardiac guidewire and catheters market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2014-2018 and expected to dominate over 2019-2025 owing to grow in prevalence of cardiac disorders in U.S. and Canada. For instance, according to Centre for Disease Control and Prevention, approximately 610,000 people die of CVDs every year. In addition, rise in demand for minimally invasive surgical procedures, and increase in healthcare expenditure are propel the market in North America region. Asia Pacific cardiac guidewire and catheters market projected to exhibit lucrative opportunities due to entry of market players into emerging countries such as India and China, rise in medical tourism, and development in healthcare infrastructure in the region.

 

 

Launch of newer products, frequent product approvals, and strategic alliances are the key strategies adopted by market players

Global cardiac guidewire and catheters market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In June 2019, Terumo Corporation partnered with Orchestra Biomed, to enhance the coronary intervention product portfolio by securing exclusive global rights to Virtue, a Sirolimus-eluting balloon used for percutaneous coronary intervention.

 

Key player’s profiles in the report are Boston Scientific Corporation (U.S), Abbott Laboratories (U.S), Medtronic, Inc. (U.S), Livanova Plc, (U.K), Terumo Medical Corporation (Japan), Maquet (Germany), OrbusNeich (Hong Kong), Johnson & Johnson Services Inc., (U.S), Cordis Corporation (U.S), and Biotronik (Germany)

Detailed Segmentation

 

By Product Type

• Coronary Balloons
• Diagnostic Catheters
• Aspiration Catheters
• Guide catheter
• Others

By End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

Geography

 

• North America

• U.S
• Canada

• Europe

• Germany
• France
• U.K
• Italy
• Spain
• Russia
• Poland
• Rest of Europe

• Asia-Pacific

• Japan
• China
• India
• Australia & New Zealand
• ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
• South Korea
• Rest of Asia-Pacific

• Latin America

• Brazil
• Mexico
• Argentina
• Rest of Latin America

• Middle East and Africa (MEA)

• Gulf Cooperation Council (GCC) Countries
• Israel
• South Africa
• Rest of MEA

 

For more information: https://www.precisionbusinessinsights.com/market-reports/global-cardiac-guide-wire-catheters-market/

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customized market research services based on our client needs.

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com